Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CANCNASDAQ:DEMZNASDAQ:PABDNASDAQ:SARK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANCTema Oncology ETF$24.77+0.5%$24.18$20.10▼$30.11$67.13M1.1112,043 shs18,850 shsDEMZDemocratic Large Cap Core ETF$34.27+0.8%$34.04$29.70▼$37.97$39.43M1.043,427 shs3,342 shsPABDiShares Paris-Aligned Climate MSCI World ex USA ETF$56.73+0.6%$54.36$49.12▼$57.52$141.26M0.7820,409 shs183 shsSARKTradr 2X Short Innovation Daily ETF$50.04-0.6%$50.23$27.86▼$132.54$44.47M-1.62285,312 shs37,272 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANCTema Oncology ETF+2.13%+6.21%+0.45%-3.67%-5.01%DEMZDemocratic Large Cap Core ETF+0.01%+7.01%-0.35%-8.74%+6.20%PABDiShares Paris-Aligned Climate MSCI World ex USA ETF+0.59%+4.51%+3.73%+6.16%+9.81%SARKTradr 2X Short Innovation Daily ETF-0.10%-13.63%+1.70%+46.14%-44.91%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCANCTema Oncology ETFN/AN/AN/AN/AN/AN/AN/AN/ADEMZDemocratic Large Cap Core ETFN/AN/AN/AN/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/AN/AN/AN/AN/AN/AN/ASARKTradr 2X Short Innovation Daily ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANCTema Oncology ETF 2.80Moderate Buy$24.77N/ADEMZDemocratic Large Cap Core ETF 2.68Moderate Buy$34.27N/APABDiShares Paris-Aligned Climate MSCI World ex USA ETF 3.17Buy$56.73N/ASARKTradr 2X Short Innovation Daily ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANCTema Oncology ETFN/AN/AN/AN/AN/AN/ADEMZDemocratic Large Cap Core ETFN/AN/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/AN/AN/AN/AN/ASARKTradr 2X Short Innovation Daily ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANCTema Oncology ETFN/AN/A20.79∞N/AN/AN/AN/AN/ADEMZDemocratic Large Cap Core ETFN/AN/A26.43∞N/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/A16.88∞N/AN/AN/AN/AN/ASARKTradr 2X Short Innovation Daily ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANCTema Oncology ETF$0.722.91%N/AN/AN/ADEMZDemocratic Large Cap Core ETF$0.190.55%N/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETF$1.462.57%N/AN/AN/ASARKTradr 2X Short Innovation Daily ETF$6.5113.01%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANCTema Oncology ETFN/ADEMZDemocratic Large Cap Core ETFN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/ASARKTradr 2X Short Innovation Daily ETFN/AInsider OwnershipCompanyInsider OwnershipCANCTema Oncology ETFN/ADEMZDemocratic Large Cap Core ETFN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/ASARKTradr 2X Short Innovation Daily ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANCTema Oncology ETFN/A2.71 millionN/ANot OptionableDEMZDemocratic Large Cap Core ETFN/A1.15 millionN/ANot OptionablePABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/A2.49 millionN/AN/ASARKTradr 2X Short Innovation Daily ETFN/A890,000N/AOptionableSARK, CANC, PABD, and DEMZ HeadlinesRecent News About These CompaniesTradr 2X Short Innovation Daily ETF (NASDAQ:SARK) Short Interest UpdateApril 27 at 2:41 AM | americanbankingnews.comTradr 2X Short TSLA Daily ETF Short Interest Report | NASDAQ:TSLQ | BenzingaApril 24, 2025 | benzinga.comTradr 2X Short Innovation Daily ETFApril 5, 2025 | morningstar.comTop Performing Leveraged/Inverse ETFs: 03/16/2025March 19, 2025 | etftrends.comTop Performing Leveraged/Inverse ETFs: 03/02/2025March 5, 2025 | etftrends.comTop Performing Leveraged/Inverse ETFs: 02/23/2025February 25, 2025 | etftrends.comLearn to Evaluate (SARK) using the ChartsJanuary 17, 2025 | news.stocktradersdaily.com(SARK) Investment ReportDecember 17, 2024 | news.stocktradersdaily.com(SARK) Trading SignalsDecember 6, 2024 | news.stocktradersdaily.com(SARK) Pivots Trading Plans and Risk ControlsNovember 15, 2024 | news.stocktradersdaily.com(SARK) Technical DataNovember 5, 2024 | news.stocktradersdaily.com(SARK) Proactive StrategiesOctober 14, 2024 | news.stocktradersdaily.comInvestment Managers Series Trust II - Tradr 2X Long Triple Q Quarterly ETFOctober 3, 2024 | money.usnews.comInvestment Managers Series Trust II - Tradr 2X Long SPY Quarterly ETFOctober 3, 2024 | money.usnews.comWhen (SARK) Moves Investors should ListenSeptember 23, 2024 | news.stocktradersdaily.comSPYB Tradr 2X Long SPY Weekly ETFSeptember 18, 2024 | seekingalpha.comTradr 2X Long SOXX Weekly ETF (SOXW)September 11, 2024 | investing.comTradr 2X Long SPY Weekly (SPYB)September 11, 2024 | investing.comInvestment Managers Series Trust II - Tradr 2X Long SPY Weekly ETFSeptember 5, 2024 | money.usnews.comInvestment Managers Series Trust II - Tradr 2X Long SOXX Monthly ETFSeptember 5, 2024 | money.usnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSARK, CANC, PABD, and DEMZ Company DescriptionsTema Oncology ETF NASDAQ:CANC$24.77 +0.13 (+0.53%) As of 03:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.Democratic Large Cap Core ETF NASDAQ:DEMZ$34.27 +0.28 (+0.83%) As of 03:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Democratic Large Cap Core ETF (DEMZ) is an exchange-traded fund that is based on the Democratic Large Cap Core index. The fund tracks an index of US large-cap companies whose employees are highly supportive of Democratic candidates. DEMZ was launched on Nov 2, 2020 and is managed by RAM.iShares Paris-Aligned Climate MSCI World ex USA ETF NASDAQ:PABD$56.73 +0.33 (+0.59%) As of 04/28/2025 09:30 AM EasternThe iShares Paris-Aligned Climate MSCI World ex USA ETF (PABD) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a tier-weighted index of large- and mid-cap stocks in developed markets excluding the US. The fund utilizes ESG criteria aligned with the Paris Climate Agreement when selecting and weighing securities. PABD was launched on Feb 8, 2022 and is issued by BlackRock.Tradr 2X Short Innovation Daily ETF NASDAQ:SARK$50.04 -0.32 (-0.64%) As of 03:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The AXS Short Innovation Daily ETF (SARK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed fund that seeks to achieve -1x the return, for a single day, of the ARK Innovation ETF (ARKK) through swap agreements with major global financial institutions. SARK was launched on Nov 9, 2021 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Coca-Cola Company Stock Can Bubble to New Highs This Year Intel: Good Quarter, Bad Vibes, Guidance Rattles Investors Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet Domino’s Pizza Builds Leverage: Analysts Raise Price Targets 5 Mid-Cap Stocks Insiders Are Buying This Year Alphabet Rebounds After Strong Earnings and Buyback Announcement Occidental’s Hidden Gem: How OxyChem Could Boost Profits T-Mobile US: The Un-Carrier Is an Indisputable Buy on the Dip Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
